The Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes Human Plasmacytoid and Myeloid Dendritic Cell Development from CD34 <sup>+</sup> Hematopoietic Progenitor Cells
Soley Thordardottir(Radboud University Nijmegen), Harry Dolstra(Radboud University Nijmegen), Timothy R. D. J. Radstake(Radboud University Nijmegen), Tim J A Hutten(Radboud University Nijmegen), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Marta Cossu(University Medical Center Utrecht), Basav N. Hangalapura(Radboud University Nijmegen), Robbert van der Voort(Radboud University Nijmegen), Nicolaas Schaap(Radboud University Nijmegen)
Cited by 67
Related Papers
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
|Clinical Cancer Research|2017|211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
|Frontiers in Immunology|2017|197